Starting 2016 with a bang, VC4A listed venture AzarGen Biotechnologies closes $3.1 million in Series B funding. We had a chance to speak with… read more
Over the past few years we have seen improvements in the African healthcare sector. There is increased investment in quality hospitals and a growing… read more
